- Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseA J Olszewski
The Cancer Center at Memorial Hospital of Rhode Island, Pawtucket
Ann Oncol 24:1352-9. 2013..In those requiring systemic treatment, addition of cytotoxic chemotherapy to rituximab in the first-line regimen was not associated with improved survival...
- Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective studyAdam J Olszewski
Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA
Breast Cancer Res Treat 138:215-23. 2013..While limited by the small number of events, our analysis does not support the increasingly prevalent practice of administering adjuvant chemotherapy in this population without more accurate prognostic and predictive factors...
- Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results databaseAdam J Olszewski
Division of Hematology and Oncology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
Cancer 119:629-38. 2013..The prognosis of patients with MALT lymphoma varies according to the anatomical site of origin...
- Survival outcomes with and without splenectomy in splenic marginal zone lymphomaAdam J Olszewski
Division of Hematology Oncology, Memorial Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Am J Hematol 87:E119-22. 2012..66)or overall survival was detectable. The results strengthen the notion that, with the availability of safe and effective alternatives, splenectomy should no longer be considered the treatment of choice in SMZL...